THIS YEAR, 7.8 BILLION PEOPLE AROUND THE WORLD NEED A BETTER SOLUTION

COVID-19

Overview

An Opportunity to Help 500 Million People

The NanoDx™ System represents an opportunity to help diagnose 500 million people worldwide with COVID-191.

In 2020, 67.8 million people have been infected with COVID-19 and 1.55 million people have died.
The Challenge

EXISTING COVID-19 DIAGNOSIS HAS MANY LIMITATIONS

  • Requires sample transport to central laboratory
  • Time-consuming for patients & doctors
  • Expensive capital equipment
  • Low diagnostic sensitivity
  • Questionable quality & reliability
  • No systems connectivity
  • Requires sample transport to central laboratory
  • Time-consuming for patients & doctors
  • Expensive capital equipment
  • Low diagnostic sensitivity
  • Questionable quality & reliability
  • No systems connectivity
The Need
Patients
  • High sensitivity & reliability
  • Real-time test results
  • Flexible use in any location
Hospitals
  • No expensive capital equipment
  • Faster results for efficient patient management
  • Reduced risk of patients being misdiagnosed
Healthcare System
  • Reduced spread of virus & staff exposure
  • More effective identification of infected population
  • Significant decrease in the $4 trillion global economic burden of COVID-191
  1.  “The Economic Impact of Coronavirus,” Quartz, 2020.